Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Narrative)

v3.10.0.1
Stockholders' Equity (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 9 Months Ended
May 21, 2018
May 03, 2018
Jan. 18, 2018
May 31, 2018
Sep. 30, 2018
Aug. 06, 2018
May 14, 2018
Dec. 31, 2017
Common stock authorized         100,000,000 800,000,000   100,000,000
Common stock par value         $ 0.001 $ 0.001   $ 0.001
Common stock issued         29,923,000     24,275,000
Common stock outstanding         29,923,000     24,275,000
Reduction in common stock shares authorized           100,000,000    
Debt conversion converted instrument, shares issued 1,085,105              
Convertible note interest rate, percentage 8.00%              
Gross proceeds from public offering   $ 8,000            
Net proceeds from public offering   $ 7,684            
Underwriter [Member] | Over-Allotment Option [Member]                
Number of warrants issued to purchase common shares             225,000  
October 27, 2018 [Member] | Underwriter [Member]                
Number of common shares sold         4,210,527      
Sale of stock price per share         $ 1.767      
Number of warrants issued to purchase common shares         84,211      
Warrant exercise price per share         $ 2.09      
Public [Member] | October 27, 2018 [Member] | Underwriter [Member]                
Sale of stock price per share         $ 1.90      
Board of Directors [Member]                
Debt conversion converted instrument, shares issued       1,085,105        
Convertible note interest rate, percentage       8.00%        
Gross proceeds from public offering       $ 8,000        
Common stock reverse stock split     one-for-thirty reverse split